Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The bill amends the Public Health Service Act to explicitly allow BARDA to include manufacturing technologies, platforms, and countermeasures in its strategic initiatives and to collaborate with the Manufacturing USA network. It authorizes BARDA to work with Manufacturing USA institutes on biomanufacturing missions to develop, demonstrate, and deploy technologies and response capabilities for public health and medical preparedness.
Liberal emphasizes public-health equity and public-interest safeguards
Relative to its intended legislative type, this bill narrowly and clearly amends existing statute to authorize BARDA to collaborate with the Manufacturing USA institutes on biomanufacturing missions, integrating directly with the cited statutory authorities.
The bill amends the Public Health Service Act to explicitly allow BARDA to include manufacturing technologies, platforms, and countermeasures in its strategic initiatives and to collaborate with the Manufacturing USA network.
It authorizes BARDA to work with Manufacturing USA institutes on biomanufacturing missions to develop, demonstrate, and deploy technologies and response capabilities for public health and medical preparedness.
Modest, noncontroversial technical tweak with limited fiscal impact increases chance, but many small bills still stall in committee or await package inclusion.
Relative to its intended legislative type, this bill narrowly and clearly amends existing statute to authorize BARDA to collaborate with the Manufacturing USA institutes on biomanufacturing missions, integrating directly with the cited statutory authorities. The amendment is concise and targeted but leaves most executional details unspecified.
Liberal emphasizes public-health equity and public-interest safeguards
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberal emphasizes public-health equity and public-interest safeguards
Generally supportive because it strengthens domestic biomanufacturing capacity and preparedness for public health emergencies.
Would view it as a useful public investment if paired with equitable access, workforce development, and public-interest safeguards.
May press for stronger accountability and benefit-sharing with the public.
Cautiously supportive as a pragmatic, targeted collaboration building on existing institutes.
Values improved preparedness but wants clear oversight, performance metrics, and cost transparency to avoid duplication or mission creep.
Looks for measurable returns on federal involvement.
Somewhat supportive if framed as national security and supply-chain resilience, but wary of expanding federal industrial policy.
Prefers private-sector leadership, tight fiscal controls, and safeguards against corporate favoritism or long-term federal commitments.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Modest, noncontroversial technical tweak with limited fiscal impact increases chance, but many small bills still stall in committee or await package inclusion.
The bill has not accumulated any surfaced votes yet.
Liberal emphasizes public-health equity and public-interest safeguards
Modest, noncontroversial technical tweak with limited fiscal impact increases chance, but many small bills still stall in committee or awai…
Relative to its intended legislative type, this bill narrowly and clearly amends existing statute to authorize BARDA to collaborate with the Manufacturing USA institutes on biomanufacturing missions, integrating directl…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.